Dubduban, Baby Boy .

HRN: 23-07-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
AMPICILLIN 500MG (VIAL)
05/29/2023
06/04/2023
IV
160mg
Q12Hrs
Thickly MSAF
Checking Final Appropriateness 
05/29/2023
CEFTAZIDIME 1GM (VIAL)
05/29/2023
06/04/2023
IV
96mg
Q12Hrs
Thickly MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: